Delivery Order SPE2DB22D1017-SPE2DB24FF0WW

Award Date 1/8/24
Potential Completion Date 1/9/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply EXFORGE 10-320 MG TABLET 30S with a potential value of $12,035.52. The delivery order, which has a completion date of January 17, 2024, was awarded on January 16, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal contract awards from the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 10-320 MG TABLET 30S for a potential value of $1,504.44. The contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31,...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,817.75 firm fixed price contract is for the delivery of EXFORGE 10-160 MG TABLET 30S, a brand name pharmaceutical product. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of EXFORGE 10-320 mg tablets. The contract has a potential value of $10,323.09 and a period of performance through February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. This contract appears to be issued under a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,071.78 firm fixed price contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA to supply...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,966.10 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of February 8, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,419.41 by the Defense Logistics Agency (DLA) to provide EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of January 26, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,938.44 order is for the delivery of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, to support DLA Troop Support Medical operations. The contract has a completion date of January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,504.44 firm-fixed-price contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of October 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EXFORGE 5-160 MG TABLET 30S. The order has a completion date of January 26, 2024 and a potential value of $2,679.45. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF0WW
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of 4,563,329,789 EXFORGE 10-320 MG TABLET 30S. The contract is a firm fixed price (FFP) delivery order with a potential value of $1,504.44 and a completion date of January 9, 2024. The award was made on January 8, 2024 and there was no set-aside designation used. Amerisourcebergen Drug Corp is a for-profit organization that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense, through its Corporate Office division. The company has an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, with a potential value of $750,000 through May 2024.

Generated 4/8/24, 9:11 AM